000 | 01819 a2200481 4500 | ||
---|---|---|---|
005 | 20250514061701.0 | ||
264 | 0 | _c20030822 | |
008 | 200308s 0 0 eng d | ||
022 | _a0033-3158 | ||
024 | 7 |
_a10.1007/s00213-002-1385-7 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBalducci, C | |
245 | 0 | 0 |
_aReversal of visual attention dysfunction after AMPA lesions of the nucleus basalis magnocellularis (NBM) by the cholinesterase inhibitor donepezil and by a 5-HT1A receptor antagonist WAY 100635. _h[electronic resource] |
260 |
_bPsychopharmacology _cApr 2003 |
||
300 |
_a28-36 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAcetylcholine _xmetabolism |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAttention _xdrug effects |
650 | 0 | 4 |
_aBasal Nucleus of Meynert _xdrug effects |
650 | 0 | 4 |
_aCerebral Cortex _xenzymology |
650 | 0 | 4 |
_aCholinesterase Inhibitors _xpharmacology |
650 | 0 | 4 | _aDonepezil |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aExcitatory Amino Acid Agonists |
650 | 0 | 4 |
_aIndans _xpharmacology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aPhotic Stimulation |
650 | 0 | 4 |
_aPiperazines _xpharmacology |
650 | 0 | 4 |
_aPiperidines _xpharmacology |
650 | 0 | 4 |
_aPyridines _xpharmacology |
650 | 0 | 4 | _aRats |
650 | 0 | 4 |
_aReceptors, Serotonin _xdrug effects |
650 | 0 | 4 | _aReceptors, Serotonin, 5-HT1 |
650 | 0 | 4 |
_aSerotonin Antagonists _xpharmacology |
650 | 0 | 4 | _aalpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid |
700 | 1 | _aNurra, M | |
700 | 1 | _aPietropoli, A | |
700 | 1 | _aSamanin, R | |
700 | 1 | _aCarli, M | |
773 | 0 |
_tPsychopharmacology _gvol. 167 _gno. 1 _gp. 28-36 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00213-002-1385-7 _zAvailable from publisher's website |
999 |
_c12414551 _d12414551 |